Stock Earnings

Question 1

¿Cuáles son los estados financieros clave de Pharmaron Beijing Co Ltd?

Accepted Answer

Según el último estado financiero (Form-10K), Pharmaron Beijing Co Ltd tiene un total de activos de $23,927, una ganancia neta profit de $1,793

Question 2

¿Cuáles son los ratios financieros clave para PHBBF?

Accepted Answer

El ratio corriente de Pharmaron Beijing Co Ltd es 2.32, el margen neto es 14.6, las ventas por acción son $6.92.

Question 3

¿Cómo se desglosan los ingresos de Pharmaron Beijing Co Ltd por segmento o geografía?

Accepted Answer

Pharmaron Beijing Co Ltd largest revenue segment is Laboratory Services, at a revenue of 7,046,874,518 in the most earnings release.For geography, North America is the primary market for Pharmaron Beijing Co Ltd, at a revenue of 7,852,729,440.

Question 4

¿Es rentable Pharmaron Beijing Co Ltd?

Accepted Answer

yes, según los últimos estados financieros, Pharmaron Beijing Co Ltd tiene una ganancia neta profit de $1,793

Question 5

¿Tiene Pharmaron Beijing Co Ltd alguna deuda?

Accepted Answer

yes, Pharmaron Beijing Co Ltd tiene una deuda de 10,308

Question 6

¿Cuántas acciones en circulación tiene Pharmaron Beijing Co Ltd?

Accepted Answer

Pharmaron Beijing Co Ltd tiene un total de acciones en circulación de 1,778.19

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	13,544	12,275	11,537	10,266	7,443	5,133
Revenue Growth (YoY)	15%	6%	12%	38%	45%	37%
Cost of Revenue	9,011	8,091	7,422	6,501	4,767	3,214
Gross Profit	4,532	4,184	4,115	3,764	2,676	1,918
Selling, General & Admin	1,998	1,772	1,766	1,640	977	720
Research & Development	528	432	418	261	135	91
Operating Expenses	2,528	2,385	2,330	2,041	1,165	832
Other Non Operating Income (Expenses)	-22	-4	-10	-23	-3	-4
Pretax Income	1,798	2,091	1,837	1,666	1,910	1,319
Income Tax Expense	387	377	256	314	290	172
Net Income	1,512	1,793	1,601	1,374	1,661	1,172
Net Income Growth	-20%	12%	17%	-17%	42%	113.99%
Shares Outstanding (Diluted)	1,763.38	1,773.31	1,772.52	1,776.27	1,819.77	793.2
Shares Change (YoY)	0%	0%	0%	-2%	129%	20%
EPS (Diluted)	0.85	1.01	0.9	0.77	0.91	1.48
EPS Growth	-19%	12%	17%	-15%	-38%	78%
Free Cash Flow	800	536	-111	-807	-34	332
Free Cash Flow Per Share	0.45	0.3	-0.06	-0.45	-0.01	0.41
Gross Margin	33.46%	34.08%	35.66%	36.66%	35.95%	37.36%
Operating Margin	14.78%	14.64%	15.47%	16.77%	20.28%	21.15%
Profit Margin	11.16%	14.6%	13.87%	13.38%	22.31%	22.83%
Free Cash Flow Margin	5.9%	4.36%	-0.96%	-7.86%	-0.45%	6.46%
EBITDA	--	2,058	2,025	1,917	1,625	1,173
EBITDA Margin	--	16.76%	17.55%	18.67%	21.83%	22.85%
D&A For EBITDA	--	260	240	195	115	87
EBIT	2,003	1,798	1,785	1,722	1,510	1,086
EBIT Margin	14.78%	14.64%	15.47%	16.77%	20.28%	21.15%
Effective Tax Rate	21.52%	18.02%	13.93%	18.84%	15.18%	13.04%

Pharmaron Beijing Co Ltd (PHBBF) Price

PHBBF Stock Price Chart

PHBBF Income

Follow-Up Questions